[en] The transcriptional activity of the human placental lactogen genes (choriosomatomammotropic hormone, hCS) is controlled by tissue-specific enhancers located 4 kb downstream from their respective origins of transcription. The hCS-B enhancer is the strongest; its activity is mediated by synergism between two protein-binding sites (DF-3 and DF-4). The DF-4 site possesses a potential binding sequence for TEF-1, a known transcription factor. In this paper, we show by electrophoretic mobility-shift assays and antibody supershift experiments that TEF-1 does not bind to site DF-4. Mutations in the TEF-1-like binding motif of site DF-4 prevent formation of the DNA-protein complex, called complex f, in the presence of placental JEG-3 cell extracts. When HeLa cell extracts are used, another complex (complex c) is also affected. In transient expression experiments, TKCAT constructs linked to this mutated DF-4 site exhibit greatly reduced transcriptional activity when introduced into JEG-3 cells. Some cell lines contain both protein c and protein f (the proteins forming complexes c and f); when transfected, these lines display reduced DF-4-driven activity, suggesting that the two proteins could compete for the same DF-4 sequence. We conclude that protein f is important for the placenta-specific activity of the hCS-B enhancer. By UV cross-linking, we show that protein f is actually three polypeptides ranging in size from about 12 to 21 kD.
ANDRIANOPOULOS, A., and TIMBERLAKE, W.E. (1991). ATTS, a new and conserved DNA binding domain. Plant Cell 3, 747-748.
BARSH, G.S., SEEBURG, P.H., and GELINAS, R.E. (1983). The human growth hormone gene family: structure and evolution of the chromosomal locus. Nucleic Acids Res. 11, 3939-3958.
BLACKWELL, T.K., and WEINTRAUB, H. (1990). Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection. Science 250, 1104-1110.
BRADFORD, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
BÜRGLIN, T.R. (1991). The TEA domain: a novel, highly conserved DNA-binding domain. Cell 66, 11-12.
CHEN, E.Y., LIAO, Y.U., SMITH, D.H., BARRERASALDANA, H., GELINAS, R.E., and SEEBERG, P.H. (1989). The human growth hormone locus: nucleotide sequence, biology and evolution. Genomics 4, 479-497.
CONAWAY, R.C., and CONAWAY, J.W. (1993). General initiation factors for RNA polymerase II. Annu. Rev. Biochem. 62, 161-190.
DAVIDSON, I., XIAO, J.H., ROSALES, R., STAUB, A., and CHAMBON, P. (1988). The HeLa cell protein TEF-1 binds specifically and cooperatively to two SV40 enhancer motifs of unrelated sequence. Cell 54, 931-942.
FELGNER, PL., GADEK, T.R., HOLM, M., ROMAN, R., CHAN, H.W., WENZ, M., NORTHROP, J.P., RINGOLD, G.M., and DANIELSEN, M. (1987). Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Nati. Acad. Sci. USA 84, 7413-7417.
FITZPATRICK, S.L., WALKER, W.H., and SAUNDERS, G.F. (1990). DNA sequences involved in the transcriptional activation of a human placental lactogen genes. Mol. Endocrinol. 4, 1815-1826.
FRIED, M.G., and CROTHERS, D.M. (1985). Equilibria and kinetics of lac repressor-operator interaction by polyacrylamide gel electrophoresis. Nucleic Acids Res. 9, 6505-6525.
GEY, G.O., COFFMAN, W.D., and KUBICEK, M.T. (1952). Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res. 12, 264-265.
HWANG, J.J., CHAMBON, P., and DAVIDSON, I. (1993). Characterization of the transcription activation function and the DNA binding domain of transcriptional enhancer factor-1. EMBO J. 12, 2337-2348.
JACQUEMIN, P., OURY, C, PEERS, B., MORIN, A., BELAYEW, A., and MARTIAL, J.A. (1994). Characterization of a single strong tissue-specific enhancer downstream from the three human genes encoding placental lactogen. Mol. Cell. Biol. 14, 93-103.
JIANG, S.-W., and EBERHARDT, N.L. (1994). The human chorionic somatomammotropin gene enhancer is composed of multiple DNA elements that are homologous to several SV40 enhansons. J. Biol. Chem., 269, 10384-10392.
KOHLER, P.O., BRIDSON, W.E., HAMMOND, J.M., WEINTRAUB, B., KIRSHNER, M.A., and VAN THIEL, D.H. (1971). Clonal lines of human choriocarcinoma cells in culture. Acta Endocrinol. 153, 137-153.
LAUGHTON, A. (1991). DNA binding specificity of homeodomains. Biochemistry. 30, 11357-11367.
LUCKOW, B., and SCHÜTZ, G. (1987). CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res. 15, 5490.
LYTRAS, A., and CATTINI, P.A. (1993). Placenta-specific depression and enhancer activity by the combined action of DNA elements in the 3′-flanking sequences of the hCS-B gene. 75th Annual Meeting of the Endocrine Society, Las Vegas (Abstract 1554).
MANIATIS, T., GOODBOURN, S., and FISCHER, J.A. (1987). Regulation of inducible and tissue-specific gene expression. Science 236, 1237-1245.
MANLEY, J.L. (1984). Transcription of eukaryotic genes in a whole cell extract. In Transcription and Translation—A Practical Approach. B.D. Hames and S. Higgins, eds. (IRL Press, Oxford) pp. 71-87.
MILLER, W.L., and EBERHARDT, N.L. (1983). Structure and evolution of the growth hormone gene family. Endocrinol. Rev. 4, 97-130.
MITCHELL, P.J., and TJIAN, R. (1989). Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science 245, 371-378.
PATILLO, R.A., and GEY, G.O. (1968). The establishment of a cell line of human hormone-synthesizing trophoblastic cells in vitro. Cancer Res. 28, 1231-1236.
PATILLO, R.A., RUCKERT, A, HUSSA, R.O., BERNSTEIN, R., and E. DELTS,. (1971). The JAR cell line-continuous human multihormone production and controls. In Vitro 6, 398-399.
PRESTON, CM., FRAME, MC, and CAMPBELL, M.E.M. (1988). A complex formed between cell components andan HSV structural polypeptide binds to a viral immediate early gene regulatory DNA sequence. Cell 52, 425-434.
WALKER, WH., FITZPATRICK, S.L., and SAUNDERS, G.F. (1990). Human placental lactogen transcriptional enhancer. Tissue specificity and binding with specific proteins. J. Biol. Chem. 265, 12940-12948.
XIAO, JH., DAVIDSON, I., FERRANDON, D., ROSALES, R., VIGNERON, M., MACCHI, M., RUFFENACH, F., and CHAMBON, P. (1987). One cell-specific and three ubiquitous nuclear proteins bind in vitro to overlapping motifs in the domain Bl of the SV40 enhancer. EMBO J. 6, 3005-3013.
XIAO, JH., DAVIDSON, I, MATTHES, H, GARNIER, J.M., and CHAMBON, P. (1991). Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1. Cell 65, 551-568.
